Overview

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

Status:
Unknown status

Trial end date:
2020-01-01

Target enrollment:

Participant gender:

Summary

Neurotrophic keratitis (NK) is a rare degenerative corneal disease caused by altered innervation of the trigeminal nerve that leads to rupture of the corneal epithelium, the regeneration deterioration and development of corneal ulceration, their fusion, and perforation The main characteristic in the NK is a decrease or absence of corneal sensitivity.

Phase:

Phase 4

Details

Lead Sponsor:

Biotechnology Institute IMASD

Treatments:

Lubricant Eye Drops
Ophthalmic Solutions
Tetrahydrozoline